Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era
View/ Open
Author
Ng, Kenrick
Vinnakota, Krishna
Sharma, Anand
Cresswell, Joanne
Kelly, John
Dasgupta, Prokar
Vasdev, Nikhil
Attention
2299/24565
Abstract
The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.